MIRA INFORM REPORT

 

 

Report No. :

334147

Report Date :

28.07.2015

 

IDENTIFICATION DETAILS

 

Name :

SUPREEM PHARMACEUTICALS MYSORE PRIVATE LIMITED (w.e.f. 24.11.2006)

 

 

Formerly Known As :

CANDOR LABS PRIVATE LIMITED

 

 

Registered Office :

435, Double Road, Kuvempunagar, Mysore – 570 009, Karnataka

Tel. No.:

91-821-4280036

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

16.08.1996

 

 

Com. Reg. No.:

08-020988

 

 

Capital Investment / Paid-up Capital :

Rs.17.855 million

 

 

CIN No.:

[Company Identification No.]

U24231KA1996PTC020988

 

 

IEC No.:

0701009926

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AABCC9895R

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in the business of manufacturing and trading of Pharmaceuticals Items.

 

 

No. of Employees :

120 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (44)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 120000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated on 16th August 1996, and is established company having satisfactory track record.

 

The rating factor in year on year increase in sales of the company over past years, its established track record, experienced management team, sound financial risk profile and revenue marked by its moderate networth and moderate debt coverage indicators.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

In view of the company’s established track record backed by experienced promoters, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

INFORMATION PARTED BY

 

Name :

Mr. Rajesh

Designation :

Accounts Officer

Contact No.:

91-8221-224480

Date :

27.07.2015

 

 

LOCATIONS

 

Registered Office :

435, Double Road, Kuvempunagar, Mysore – 570 009, Karnataka, India

Tel. No.:

91-821-4280036/ 2544026

Fax No.:

Not Available

E-Mail :

info@supreempharma.in

marketing@supreempharma.in

purchase@supreempharma.in

supreem_finance@supreempharma.in 

supreem_admn@sify.com

supreem_fac@sify.com

supreem_admn@sify.com

Website :

http://www.supreempharma.in

 

 

Factory :

# 73, 74 and 48P-1, KIADB Industrial Area, Nanjangud – 571 302, Karnataka, India

Tel. No.:

91-8221-224478-84

Fax No.:

91-8221-224484

 

 

Marketing Office :

# 1A, 24-Ashraya Apartments, 5th Cross, Ganesha Block, Sultanpalaya, RT Nagar Post, Bangalore – 560 032, Karnataka, India

Tel. No.:

91-80-23655026

E-Mail :

marketing@supreempharma.in

supreem_mkt@sify.com

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Mr. Sadanand Nagaraja Rao

Designation :

Managing Director

Address :

435, Anand, Double Road, Kuvempunagar, Mysore – 570 002, Karnataka, India

Date of Appointment :

16.08.1996

DIN No.:

00390316

 

 

Name :

Mrs. Geetha Sadananda Nagaraja Rao

Designation :

Director

Address :

No.435, 'Anand' Double Road, Kuvempunagar, Mysore – 570 009, Karnataka, India

Date of Birth/Age :

18.04.1955

Date of Appointment :

22.01.2008

DIN No.:

01970187

 

 

KEY EXECUTIVES

 

Name :

Mr. Rajesh

Designation :

Accounts Officer

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2014

 

Names of Shareholders

 

 

No. of Shares

S.N. Rao

 

1635164

S. Mohan Rao

 

10

Jagadish Chinnappa

 

2510

Anuradh Ramesh

 

100

D.V. Gopinath

 

50100

Kshipra M. Gharpure

 

100

K.S. Nagendra

 

100

Ravi Vishwanatha

 

100

Shanthanu M. Gharpure

 

100

Suhas R.

 

50

Supriya Bhounsule

 

100

V.M. Aravind

 

100

V.M. Harini

 

100

V. Nagarathna

 

100

Madhavi Jagadish

 

1000

G. J. Bhounsule

 

1000

Praneesh S.

 

20000

Sudha Prasad

 

1000

V.R. Murali

 

500

Geetha M. Rao

 

7500

Geetha S. Rao

 

8500

H. Kalavathi

 

1800

Makrand P. Gharpure

 

1500

T. Shankar Shana

 

500

Adithaya S. Rao

 

2500

Saroja Rao

 

1000

Vasantha Avadhani

 

50000

Total

 

1785534

 

AS ON 08.06.2015

 

Names of Allottees

 

 

No. of Shares

Sadanand Nagaraja Rao

 

120000

Mohan Srinivasa Rao

 

50000

Geetha Sadananda Rao

 

10000

Adithya Sadananda Rao

 

10000

Amit Sadananda Rao

 

10000

Kalavathi Huchaiah

 

10000

Shobha Krishnappa Vokaliga

 

10000

Shankara

 

5000

Aruna Jagadish

 

20000

Kanyakumari Kumbar Thippeswamy

 

5000

Pavithra Krishnappa

 

1111

Shankar Balavinyagamurthy

 

2222

Vijayalakshmi

 

3333

Vivek Trivedi

 

1111

Total

 

257777

 

 

AS ON 30.09.2014

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the business of manufacturing and trading of Pharmaceuticals Items.

 

 

Products :

·         Bulk Stabilized Vitamins

·         Minerals

·         Nutraceuticals

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

  • Finished Goods

Countries :

  • Taiwan
  • USA
  • Nepal
  • Pakistan

 

 

Imports :

Not Available

 

 

Terms :

 

Selling :

Cash and Credit (30/ 60/ 90 days)

 

 

Purchasing :

Cash and Credit (30/ 60/ 90 days) 

 

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Mundra Enterprises

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Payment Behaviour

Market Goodwill

Overall

Not Divulged

Not Divulged

Not Divulged

Remark:

Not Divulged

 

 

·         Bheru Enterprises

·         Business Links

·         Calibre Industries

·         Cona Chemicals Private Limited

·         CV Tropical Indo Prathama

·         Euro Tech Pack

·         Fermenta Biotech

·         Gandhi Chemicals

·         Gem Corporation Private Limited

·         Haresh Oveta

·         Hindustan Phospates Private Limited

·         Jiangsu Tohope Pharmaceuticals Company Limited

·         Karnataka Chemical Industries

·         Kenko Corporation

 

 

Customers :

End Users and OEM’s

 

Reference :

Eris Lifesciences Private Limited

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Product Quality

Delivery Behaviour

Overall

Not Divulged

Not Divulged

Not Divulged

Remark:

Not Divulged

 

·         Fourrts India Lab Private Limited

·         Safetab Life Science

·         Stedman Pharmaceuticals Private Limited

·         Aglowmed Limited

·         Ajanta Pharma Limited - Chitegaon

·         ajantha pharma Limited

·         Alembic Limited - P& B Pharmaceuticals

·         Alembic Pharmaceuticals

·         Alembic Pharmaceuticals Limited-Khambhat

·         Alkem Laboratories Limited-Sikkim

·         Bajaj Healthcare – Vadodara

·         BDH Industries Limited

·         Centaur Pharmaceuticals Private Limited

·         Cipla Limited-Goa

·         Cipla Limited, Indore

·         coral laboratories Limited - Daman

·         Creative Health Care Private Limited

·         Cure Medicines

·         Dupen Lab Private Limited

·         Eisen Pharmaceuticals Company Private Limited

·         Emcure Pharma-Jammu

 

 

No. of Employees :

120 (Approximately)

 

 

Bankers :

Banker Name

State Bank of India

Branch Address

SME Branch, #7/3, MRN Signature, Vishwamanava, Double Road, Saraswathipuram, Mysore – 570 009, Karnataka, India

Person Name (With Designation)

Ms. Mohana S. (Relationship Officer)

Contact Number

91-821-2417124

Name of Account Holder

SUPREEM PHARMACEUTICALS MYSORE PRIVATE LIMITED

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Cash Credit: Rs.50.000 million

Account Operation

--

Remarks (If any)

Satisfactory. Transaction are fair. No Complaints.

 

·         ICICI Bank Limited

·         Kotak Mahindra Bank Limited

·         Axis Bank Limited

 

 

Facilities :

Secured Loans

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

LONG-TERM BORROWINGS

 

 

Term Loan:

 

 

SIDBI Loan A/c-3

0.000

16.765

SBI Term Loan-New

1.941

3.236

Corporate Loan-32258710408

3.225

4.403

KSFC Corporate Loan

7.000

0.000

KSFC Loan

33.944

0.000

Vehicle Loan:

 

 

SBI Car Loan

0.000

0.083

Total

46.110

24.487

 

 

 

Financial Institutions :

Karnataka State Financial Corporation, No.13 and 13/1, 8th Cross, Saraswathipuram, Mysore – 570 009, Karnataka, India

 

 

Auditors :

 

Name :

Srinivasa Murthy and Company

Chartered Accountants

Address :

No.552, 522/2 and 646, 1st Floor, Balaji Building, Gadi Lakanna Lane, D.D. Urs Road, Mysore – 570 001, Karnataka, India

Tel. No.:

91-821-2424616

Income-tax PAN of auditor or auditor's firm :

ALSPS3564F

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates/Subsidiaries :

Not Available

 

 

CAPITAL STRUCTURE

 

AFTER 30.09.2014

 

Authorised Capital : Rs.30.000 million

 

Issued, Subscribed & Paid-up Capital : Rs.22.462 million

 

 

AS ON 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

2000000

Equity Shares

Rs.10/- each

Rs.20.000 million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

1785534

Equity Shares

Rs.10/- each

Rs.17.855 million

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

17.855

17.855

17.855

(b) Reserves & Surplus

24.118

18.271

11.608

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

41.973

36.126

29.463

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

46.110

24.487

33.565

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

8.828

8.905

8.023

(d) Long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

54.938

33.392

41.588

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

67.740

34.672

29.650

(c) Other current liabilities

47.433

44.146

36.929

(d) Short-term provisions

4.063

5.061

3.158

Total Current Liabilities (4)

119.236

83.879

69.737

 

 

 

 

TOTAL

216.147

153.397

140.788

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

75.089

54.852

59.958

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1.028

1.028

1.028

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

2.685

6.316

6.102

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

78.802

62.196

67.088

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

24.251

10.948

13.022

(c) Trade receivables

91.761

64.981

47.950

(d) Cash and cash equivalents

1.330

0.820

0.630

(e) Short-term loans and advances

7.025

5.009

4.994

(f) Other current assets

12.978

9.443

7.104

Total Current Assets

137.345

91.201

73.700

 

 

 

 

TOTAL

216.147

153.397

140.788

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from operations

324.585

228.390

171.014

 

 

Other Income

5.802

3.797

2.528

 

 

TOTAL                                    

330.387

232.187

173.542

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Increase/ Decrease in Finished Goods

(5.487)

4.202

(0.959)

 

 

Cost of Material Consumed

244.791

157.376

116.961

 

 

Manufacturing Expenses

28.888

20.621

15.432

 

 

Office & Administration Charges

15.536

12.501

12.147

 

 

Human Resources Expenses

6.634

4.694

3.943

 

 

Selling & Distribution Charges

9.602

5.740

5.329

 

 

TOTAL                                    

299.964

205.134

152.853

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

30.423

27.053

20.689

 

 

 

 

 

Less

INTEREST & FINANCIAL CHARGES

13.014

10.874

10.805

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

17.409

16.179

9.884

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

8.623

7.458

8.392

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX

8.786

8.721

1.492

 

 

 

 

 

Less

TAX                                                                 

2.667

1.620

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX

6.119

7.101

1.492

 

 

 

 

 

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

37.862

28.307

15.171

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

3.43

3.98

0.84

 

Particulars

 

 

 

31.03.2015

Sales Turnover (Approximately)

 

 

349.600

 

 

 

 

 

The above information has been parted by Mr. Rajesh (Accounts Officer).

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current maturities of long-term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

1.89

3.11

0.87

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

9.37

11.85

12.10

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

4.08

5.72

1.07

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.21

0.24

0.05

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.10

0.68

1.14

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.15

1.09

1.06

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particulars

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

17.855

17.855

17.855

Reserves & Surplus

11.608

18.271

24.118

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

29.463

36.126

41.973

 

 

 

 

Long-term borrowings

33.565

24.487

46.110

Short term borrowings

0.000

0.000

0.000

Total borrowings

33.565

24.487

46.110

Debt/Equity ratio

1.139

0.678

1.099

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Revenue from operations

171.014

228.390

324.585

 

 

33.550

42.119

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Revenue from operations

171.014

228.390

324.585

Profit

1.492

7.101

6.119

 

0.87%

3.11%

1.89%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity-Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

No

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

Yes

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last four years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 


FINANCIAL RESULTS

 

The company has achieved turnover of Rs.335.875 million as against Rs.227.985 million previous year and has achieved a Net Profit of Rs.6.119 million (after depreciation and tax). In spite of volatile markets and cutthroat competition, the directors have managed to overcome all the obstacles, increase the turnover of the company and in keeping company on the track of profit. Further, Sufficient measures have been taken by the directors for improving the profitability of the company and are confident of improving the company’s performance in the coming years.

 

 

INDEX OF CHARGES:

 

S. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10566618

04/03/2015

20,000,000.00

KARNATAKA STATE FINANCIAL CORPORATION

NO.13 AND 13/1, 8TH CROSS, SARASWATHIPURAM, MYSORE – 570 009, KARNATAKA, INDIA

C52255510

2

10484792

15/02/2014

7,000,000.00

KARNATAKA STATE FINANCIAL CORPORATION

# 13 AND 13/1, 8TH CROSS, SARASWATHIPURAM, MYSORE – 570 009, KARNATAKA, INDIA

C00481366

3

10453545

09/10/2013

43,000,000.00

KARNATAKA STATE FINANCIAL CORPORATION

# 13 AND 13/1, 8TH CROSS, SARASWATHIPURAM, MYSORE – 570 009, KARNATAKA, INDIA

B86870698

4

10081897

04/03/2013 *

78,900,000.00

STATE BANK OF INDIA

SME BRANCH, #7/3, MRN SIGNATURE, VISHWAMANAVA, DOUBLE ROAD, SARASWATHIPURAM, MYSORE – 570 009, KARNATAKA, INDIA

B71615611

5

80040389

20/09/2002

3,525,000.00

STATE BANK OF INDIA

VIVEKANANDA ROAD, MYSORE – 570 020, KARNATAKA, INDIA

-

 

* Date of charge modification

 

FIXED ASSETS:

 

Tangible Assets

·         Land

·         Building

·         Furniture and Fixtures

·         Office Equipment

·         Vehicles

·         Plant and machinery -Others

·         Lab Equipments (P/M)

·         Computers - Hardware

Intangible Assets

·         Computers - Software

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs.64.00

UK Pound

1

Rs.99.43

Euro

1

Rs.70.61                 

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

KAS

 

 

Report Prepared by :

SMN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

4

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.